(NP (NP Photoaffinity/NN labeling/NN) (PP of/IN (NP (NP plasma/NN membrane/NN receptors/NNS) (PP for/IN (NP aldosterone/NN)) (PP from/IN (NP human/JJ mononuclear/JJ leukocytes/NNS)))) ./.)
(S (NP-SBJ-1 (NP Non-genomic/JJ effects/NNS) (PP of/IN (NP aldosterone/NN)) (PP on/IN (NP the/DT sodium-proton-antiport/NN))) (VP have/VBP (VP been/VBN (VP shown/VBN (NP *-1/-NONE-) (PP in/IN (NP (NP human/JJ mononuclear/JJ leukocytes/NNS) (SBAR (WHNP-2 which/WDT) (S (NP-SBJ *T*-2/-NONE-) (VP could/MD (VP be/VB (ADJP-PRD related/JJ (PP to/TO (NP a/DT new/JJ aldosterone/NN membrane/NN receptor/NN)))))))))))) ./.)
(S (PP In/IN (NP the/DT present/JJ paper/NN)) (NP-SBJ-4 (NP plasma/NN membranes/NNS) (PP from/IN (NP human/JJ mononuclear/JJ leukocytes/NNS))) (VP were/VBD (ADVP covalently/RB) (VP photolabeled/VBN (NP *-4/-NONE-) (PP with/IN (NP a/DT -LCB-125I-RCB--aldosterone/NN derivative/NN)))) ./.)
(S (NP-SBJ (ADJP Sodium/NN dodecyl/NN sulfate-polyacrylamide/JJ) gel/NN electrophoresis/NN) (VP showed/VBD (NP (NP significant/JJ aldosterone/NN binding/NN) (PP at/IN (NP (NP a/DT molecular/JJ weight/NN) (PP of/IN (NP (QP approximately/RB 50000/CD) Dalton/NN))))) (SBAR (WHNP-5 which/WDT) (S (NP-SBJ *T*-5/-NONE-) (VP was/VBD (ADJP-PRD absent/JJ) (PP with/IN (NP (NP-COOD (NP (NP 1/CD microM/NN) (NP cold/JJ aldosterone/NN)) ,/, (CONJP but/CC not/RB) (NP cortisol/NN)) (PP in/IN (NP the/DT binding/VBG media/NNS)))))))) ./.)
(S (NP-SBJ (NP The/DT presence/NN) (PP of/IN (NP the/DT sulfhydryl/NN agent/NN dithiothreitol/NN))) (VP did/VBD not/RB (VP affect/VB (NP (NP results/NNS) (VP suggesting/VBG (NP (NP the/DT absence/NN) (PP of/IN (NP disulfide/NN bridges/NNS)) (PP in/IN (NP (NP the/DT steroid/NN binding/NN domain/NN) (PP of/IN (NP the/DT receptor/NN))))))))) ./.)
(S (NP-SBJ These/DT data/NNS) (VP are/VBP (NP-PRD (NP the/DT first/JJ) (SBAR (WHNP-100 0/-NONE-) (S (NP-SBJ *T*-100/-NONE-) (VP to/TO (VP define/VB (NP (NP the/DT molecular/JJ weight/NN) (PP of/IN (NP (NP the/DT membrane/NN receptor/NN) (PP for/IN (NP aldosterone/NN))))))))))) ./.)
